Low-Dose Radiation Promotes the Proliferation and Migration of AGE-Treated Endothelial Progenitor Cells Derived from Bone Marrow via Activating SDF-1/CXCR4/ERK Signaling Pathway

2019 ◽  
Vol 191 (6) ◽  
pp. 518 ◽  
Author(s):  
Ping Wang ◽  
Haifeng Zhang ◽  
Zhuo Li ◽  
Xiaobo Liu ◽  
Yingli Jin ◽  
...  
2020 ◽  
Vol Volume 13 ◽  
pp. 3619-3629
Author(s):  
Jing Li ◽  
Dong-ming Wu ◽  
Rong Han ◽  
Ye Yu ◽  
Shi-hua Deng ◽  
...  

2005 ◽  
Vol 80 (11) ◽  
pp. 1541-1545 ◽  
Author(s):  
Jonathan D. Powell ◽  
Courtney Fitzhugh ◽  
Elizabeth M. Kang ◽  
Mathew Hsieh ◽  
Ronald H. Schwartz ◽  
...  

2015 ◽  
Vol 10 (2) ◽  
pp. 1934578X1501000 ◽  
Author(s):  
Peng Zhang ◽  
Guohua Han ◽  
Pei Gao ◽  
Kun Qiao ◽  
Yusheng Ren ◽  
...  

For this study, peripheral blood samples were collected from human volunteers. Mononuclear cells (MNC) were separated by density centrifugation and were induced to differentiate into endothelial progenitor cells (EPCs) in vitro. Different concentrations of rapamycin and silymarin were introduced to the EPCs over 24 hours and then EPCs were analyzed for proliferation, migration, apoptosis and angiogenesis. Compared with the control group, rapamycin (1, 10, 100 ng/mL) inhibited the proliferation and migration of EPCs in a concentration dependent manner ( P<0.05). Silymarin (50, 100 μg/mL) enhanced the proliferation and migration of EPCs and inhibited apoptosis in a concentration dependent manner ( P<0.05). By adding rapamycin (1 ng/mL) and silymarin (25, 50, 100 μg/mL) over 24 hours, silymarin inhibited the pro-apoptotic effect of rapamycin on EPCs, and reversed the inhibition of proliferation, migration and angiogenesis of EPCs by rapamycin ( P<0.05).


Dose-Response ◽  
2012 ◽  
Vol 11 (3) ◽  
pp. dose-response.1 ◽  
Author(s):  
Sung Hak Chun ◽  
Ga-Young Park ◽  
Yu Kyeong Han ◽  
Sung Dae Kim ◽  
Joong Sun Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document